dibenzo(a,l)pyrene has been researched along with nu 7026 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Ferlińska, M; Nocuń, M; Roszak, J; Smok-Pieniążek, A; Spryszyńska, S; Stępnik, M | 1 |
Brodecki, M; Domeradzka Gajda, K; Kowalczyk, K; Roszak, J; Sobańska, Z; Stępnik, M; Szparaga, M | 1 |
2 other study(ies) available for dibenzo(a,l)pyrene and nu 7026
Article | Year |
---|---|
The influence of ATM, ATR, DNA-PK inhibitors on the cytotoxic and genotoxic effects of dibenzo[def,p]chrysene on human hepatocellular cancer cell line HepG2.
Topics: Apoptosis; Ataxia Telangiectasia Mutated Proteins; Benzopyrenes; Caffeine; Cell Proliferation; Chromones; Cytotoxins; DNA Breaks, Single-Stranded; DNA-Activated Protein Kinase; Hep G2 Cells; Humans; Morpholines; Mutagens; Protein Kinase Inhibitors; Pyrones; Reactive Oxygen Species | 2015 |
The effect of inhibitors of phosphatidylinositol 3-kinase-related kinases on dibenzo[def,p]chrysene genotoxicity measured by γH2AX levels and neutral comet assay in HepG2 human hepatocellular cancer cells.
Topics: Benzopyrenes; Carcinoma, Hepatocellular; Cell Survival; Chromones; Comet Assay; DNA Damage; Hep G2 Cells; Histones; Humans; Liver Neoplasms; Morpholines; Phosphatidylinositol 3-Kinase; Protein Kinase Inhibitors | 2020 |